Drugs / HIV-v
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01071031 | Nov 2009 → Apr 2011 | HIV infectious disease | PepTcell Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV-v | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01071031 ↗ |
| Modality | Peptide | “a sterile lyophilised mixture of polypeptide T-cell epitope sequences” NCT01071031 ↗ |
| Route | Subcutaneous | “Administration: A single subcutaneous injection” NCT01071031 ↗ |